10 Aug, 2026
1 min read

HKG:3613 Tong Ren Tang

HKG:3613 Tong Ren Tang 1H 2022 a special dividend was announced. Final dividend got a raise of 17%. This company is heading to become dividend contender next year. And let’s not forget the beautiful dividend chart. The special dividends is left out conveniently.

1 min read

HKG:1681 Consun Pharm

HKG:1681 Consun Pharm The pharmaceutical products of the Company include kidney medicines, contrast medium and others. The Company’s subsidiaries include Brilliant Reach Group Limited, Century International Develop Limited and Grand Reach Company Limited. Through its subsidiaries, the Company is also engaged in the research and development of pharmaceutical products.

1 min read

Hansoh Pharma HKG:3692 – Hong Kong Blue Chip stock

Hansoh Pharma (HKG:3692) Hong Kong Blue Chip Stock • Sector: Medicine Last updated: 3-Jul Next ex-dividend date: 3-Jul 0 Stock Value Score This score indicates whether the stock currently appears undervalued, fairly priced, or expensive, based on key valuation metrics such as earnings, book value, and cash flow. P/E ratio 27.68 P/B ratio 4.39 EPS […]

1 min read

SinoPharm HKG:1099 – Hong Kong Blue Chip stock

SinoPharm (HKG:1099) Hong Kong Blue Chip Stock • Sector: Medicine Last updated: 3-Jul Next ex-dividend date: 23-Jun The company distributes medicine to hospitals, pharmacies, and clinics. They also run pharmacy stores, distribute medical devices and laboratory supplies, make chemical reagents, and sell pharmaceutical products. Stock Value Score This score indicates whether the stock currently appears […]

1 min read

Innovent Bio HKG:1801 – Hong Kong Blue Chip stock

Innovent Bio (HKG:1801) Hong Kong Blue Chip Stock • Sector: Medicine Last updated: 3-Jul Next ex-dividend date: N/A Innovent Biologics Inc. (1801.HK) is a leading Chinese biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative oncology, autoimmune, and metabolic disease therapies. The company has built a strong pipeline of biologic drugs and […]

1 min read

HKG:0867 CMS

HKG:0867 CMS What a beautiful chart! Results of 2022 are okay. Dividends got up 2.5% , Debt/Equity remained stable.  This looks promising  in terms of higher proceeds of holding this stock. (Average 5-yr Dividend Growth is almost 15%)